Every law firm that pursues aggressive growth eventually confronts the same uncomfortable tension between expanding its reach and protecting what made it worth growing in the first place. Scott Rahn, Founding Partner
The U.S. Securities and Exchange Commission announced the establishment of a new financial reporting and accounting unit within its enforcement division on August 5, 2026. This marks the second targeted enforcement unit
More
Released documents obtained through a Freedom of Information Act request expose the extent of FCC chairman Brendan Carr’s collaboration with the White House and right-wing organisations. The records were secured by the
More
International Business Machines (IBM) has emerged as a notable large-cap software pick for investors navigating an increasingly stretched US equity market in 2026. US stock market valuations have climbed to elevated levels,
More
The Premier League’s voluntary ban on gambling brands from front-of-shirt advertising has triggered a major commercial reshuffling across all 20 top-flight clubs this season. The 20 clubs agreed collectively to remove betting
More
Novo Nordisk is pushing forward with a new late-stage clinical study testing smaller doses of its oral semaglutide obesity treatment, known as the Wegovy pill. The OASIS 5 trial launched just eight
More
Pennsylvania Governor Josh Shapiro has signed Executive Order 2026-05, transforming the state’s voluntary GRID Requirements into binding conditions for data center developers. The order ties compliance with the Governor’s Responsible Infrastructure Development
More
When summer arrives, it is common for law firm partners to take extended vacations, stepping away from the office for a week or two at a stretch. Partners generally have far greater
More
The United States government periodically issues tariff refunds to companies that successfully contest import duties, creating pockets of unexpected cash on corporate balance sheets. Consumer-facing businesses are among the most active claimants,
More
The FTSE 100 ended the week on a positive note, buoyed by encouraging private sector data and a continued rally in gold prices. Gold’s sustained climb provided significant support to mining and
More
Eli Lilly’s once-weekly injectable insulin, Onswik, has received a positive recommendation from the UK’s drug cost watchdog, moving it closer to NHS availability for type 2 diabetes patients. The National Institute for
More